Adding local treatment to drug therapy for stage IV lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial compares continuing drug therapy alone versus adding local treatments (surgery or radiation) for people with stage IV lung cancer that has responded to initial treatment but still has a few remaining spots (oligometastatic). The goal is to see if targeting those spots with local therapy helps control the cancer longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have stage IV non-small cell lung cancer (confirmed by biopsy) and have not had treatment yet
- You are able to carry out most daily activities (ECOG score 0 or 1)
- After 3 months of standard drug treatment (first line), scans show the cancer has shrunk or stayed the same, and you have at most 5 remaining spots outside the brain (plus up to 5 in the brain)
- All remaining tumors can be treated with surgery or radiation (radical treatment)
- If you could become pregnant, you agree to use two forms of birth control during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding local treatments like radiation or surgery to standard immunotherapy can help people with lung cancer that has spread to a few spots. It aims to see if this combination improves control of the disease.
This trial compares two approaches after initial chemotherapy and immunotherapy for advanced non-small cell lung cancer: giving additional local treatment (like surgery or radiation) to remaining spots versus continuing immunotherapy. It aims to see which strategy better controls the cancer.
This trial tests whether directly treating the remaining lung tumor with surgery or radiation, after initial chemo and osimertinib, can improve outcomes for people with advanced EGFR-mutant non-small cell lung cancer.
This trial tests whether adding local treatments like radiation or surgery to standard therapy can help control cancer that has started to grow in just a few spots. It is for people with certain advanced cancers that have 1 to 5 growing lesions that can be treated locally.
This trial tests whether adding a high, focused dose of radiation to the usual first treatment (chemo and/or immunotherapy) can help people with non-small cell lung cancer that has spread to a limited number of spots (up to 5). The goal is to see if this approach improves how well the treatment works.
This study is for people with solid tumors that have spread to a few spots (5 or fewer) in the body. It tests whether using a focused treatment like radiation or ablation on those spots can help control the cancer long-term.
Hear when a new Non-small Cell Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.